Real-world variability in dabigatran levels in patients with atrial fibrillation: reply

J Thromb Haemost. 2015 Jun;13(6):1168-9. doi: 10.1111/jth.12906. Epub 2015 Apr 13.

Authors

N C Chan¹, J Hirsh², J S Ginsberg^{2

3}, J W Eikelboom^{1

2

3}

Affiliations

¹ Population Health Research Institute, Hamilton, ON, Canada.
² Department of Medicine, McMaster University, Hamilton, ON, Canada.
³ Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada.

PMID: 25786778
DOI: 10.1111/jth.12906

No abstract available

Publication types

Letter
Kommentar

MeSH terms

Antithrombins / blood*
Atrial Fibrillation / drug therapy*
Blood Coagulation / drug effects*
Dabigatran / blood*
Female
Humans
Male

Substances

Antithrombins
Dabigatran